D3461C00009: A Multicentre, Randomised, Double-blind, Pl

Project: Research project

Project Details

Description

D3461C00009: A Multicentre, Randomised, Double-blind, Placebo-Controlled Phase 3 Extension Study to Characterise the Long-term Safety and Tolerability of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
StatusActive
Effective start/end date11/1/1712/31/22

Funding

  • AstraZeneca

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.